English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/163333
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

DC FieldValueLanguage
dc.contributor.authorDobrzynska, Agnieszka-
dc.contributor.authorAskjaer, Peter-
dc.contributor.authorGruenbaum, Yosef-
dc.date.accessioned2018-04-09T11:07:41Z-
dc.date.available2018-04-09T11:07:41Z-
dc.date.issued2016-
dc.identifierdoi: 10.1016/bs.mie.2015.08.036-
dc.identifierissn: 0076-6879-
dc.identifiere-issn: 1557-7988-
dc.identifier.citationMethods in Enzymology 569: 455-483 (2016)-
dc.identifier.urihttp://hdl.handle.net/10261/163333-
dc.description.abstractThe nuclear lamina, composed of lamins and numerous lamin-associated proteins, is required for mechanical stability, mechanosensing, chromatin organization, developmental gene regulation, mRNA transcription, DNA replication, nuclear assembly, and nuclear positioning. Mutations in lamins or lamin-binding proteins cause at least 18 distinct human diseases that affect specific tissues such as muscle, adipose, bone, nerve, or skin, and range from muscular dystrophies to lipodystrophy, peripheral neuropathy, or accelerated aging. Caenorhabditis elegans has unique advantages in studying lamin-binding proteins. These advantages include the low complexity of genes encoding lamin and lamin-binding proteins, advanced transgenic techniques, simple application of RNA interference, sophisticated genetic strategies, and a large collection of mutant lines. This chapter provides detailed and comprehensive protocols for the genetic and phenotypic analysis of lamin-binding proteins in C. elegans.-
dc.description.sponsorshipWe gratefully acknowledge Georgina Gómez-Saldivar for discussion on the DamID protocol and funding from the Muscular Dystrophy Association (MDA), the Binational Israel-USA Science Foundation (BSF 2007215), and the Niedersachsen-Israeli Research Cooperation program to Y.G. and funding from the Spanish Ministry of Economy and Competitiveness (BFU2013-42709P), the Autonomous Government of Andalusia (P08-CVI-3920), and the European Regional Development Fund to P.A.-
dc.publisherElsevier-
dc.relationMINECO/ICTI2013-2016/BFU2013-42709-P-
dc.rightsclosedAccess-
dc.subjectBAF-1-
dc.subjectChIP-
dc.subjectCRISPR-
dc.subjectDamID-
dc.subjectFRET-
dc.subjectEmerin-
dc.subjectLamin-
dc.subjectFLIP-
dc.titleLamin binding proteins in Caenorhabditis elegans-
dc.typeartículo-
dc.date.updated2018-04-09T11:07:41Z-
dc.description.versionPeer Reviewed-
dc.language.rfc3066eng-
dc.contributor.funderEuropean Commission-
dc.contributor.funderMuscular Dystrophy Association (US)-
dc.contributor.funderJunta de Andalucía-
dc.contributor.funderMinisterio de Economía y Competitividad (España)-
dc.contributor.funderUnited States-Israel Binational Science Foundation-
dc.relation.csic-
dc.identifier.funderhttp://dx.doi.org/10.13039/501100000780es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/100005202es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100003329es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100001742es_ES
dc.identifier.pmid26778571-
Appears in Collections:(CABD) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show simple item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.